Adeno-associated viral (AAV) mediated gene replacement therapy for SLC25A4 deficiency
Conferences
Benkert, AR; Wolfson, D; Gonzalez, TJ; Sewell, B; Fergione, SA; Strauss, KA; Asokan, A
Published in: HUMAN GENE THERAPY
February 1, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
February 1, 2025
Volume
36
Issue
3-4
Start / End Page
E258 / E258
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
Citation
APA
Chicago
ICMJE
MLA
NLM
Benkert, A. R., Wolfson, D., Gonzalez, T. J., Sewell, B., Fergione, S. A., Strauss, K. A., & Asokan, A. (2025). Adeno-associated viral (AAV) mediated gene replacement therapy for SLC25A4 deficiency. In HUMAN GENE THERAPY (Vol. 36, pp. E258–E258).
Benkert, A. R., D. Wolfson, T. J. Gonzalez, B. Sewell, S. A. Fergione, K. A. Strauss, and A. Asokan. “Adeno-associated viral (AAV) mediated gene replacement therapy for SLC25A4 deficiency.” In HUMAN GENE THERAPY, 36:E258–E258, 2025.
Benkert AR, Wolfson D, Gonzalez TJ, Sewell B, Fergione SA, Strauss KA, et al. Adeno-associated viral (AAV) mediated gene replacement therapy for SLC25A4 deficiency. In: HUMAN GENE THERAPY. 2025. p. E258–E258.
Benkert, A. R., et al. “Adeno-associated viral (AAV) mediated gene replacement therapy for SLC25A4 deficiency.” HUMAN GENE THERAPY, vol. 36, no. 3–4, 2025, pp. E258–E258.
Benkert AR, Wolfson D, Gonzalez TJ, Sewell B, Fergione SA, Strauss KA, Asokan A. Adeno-associated viral (AAV) mediated gene replacement therapy for SLC25A4 deficiency. HUMAN GENE THERAPY. 2025. p. E258–E258.
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
February 1, 2025
Volume
36
Issue
3-4
Start / End Page
E258 / E258
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology